REBMANN RESEARCH
REBMANN RESEARCH provides proprietary economic data and cloud-based analytics tools covering 60 healthcare sectors, serving financial consultants, medical practice owners, banks, and insurers in Europe and Latin America through products like Atlas Medicus, Medicus ONE, CURE Praxismanager, and Finoso.
- Company typePrivate
- Founded1998
- HeadquartersSchramberg, Germany
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What REBMANN RESEARCH does
REBMANN RESEARCH, founded in 1998 and headquartered in Schramberg, Germany, provides proprietary economic data and digital analytics tools for the healthcare market. The company maintains a proprietary database covering approximately 60 healthcare sectors, drawing on over 500 distinct data sources for major publications, and serves specialized financial, tax, and business consultants serving medical practices (Heilberufeberater), practice owners, banks, insurance companies, medical technology firms, and public institutions. Its product portfolio centers on four cloud-based software tools: Atlas Medicus (market information system and competitive analysis toolbox), Guided Medicus (strategic consulting and business planning), Medicus ONE (real-time practice controlling via bank account integration with ML/AI interpretation), and Finoso (DIN 77230/77235-certified financial advisory software). Supporting technologies include the European-patented Atlas Explorer text-to-database engine and Hit-O-Meter navigation tool, plus the CURE Praxismanager Open Banking platform acquired through a majority stake in CURE Vertical Finance GmbH in February 2024.
The business operates through a hybrid revenue model combining software subscriptions (Atlas Medicus, Guided Medicus, Medicus ONE, Finoso), publication licensing for the Atlas Dental market research series (priced at €900-960 per long-version license), white-label/embedded partnerships with banks and consulting firms, and commissioned sponsored studies for industry associations such as GFDI/VDDI. Distribution combines direct digital channels (online portal with freemium trial), white-label embedded partner channels (KOCK CONSULTING, medondo AG, FINO Software), and event-driven engagement through the Forum Medicum brand. The company maintains offices in Schramberg (headquarters), Berlin (operations and CURE subsidiary), and Herrenberg (development), with a global footprint spanning Europe, North America, Latin America/Caribbean, Asia, and Africa through its dental market publications. It operates as an owner-managed GmbH & Co. KG with no disclosed external investors.
Key strategic positioning rests on domain specialization: the dataset and tooling are built specifically for healthcare market economics rather than adapted from generic business intelligence platforms. Notable enterprise relationships include Deutsche Bank, DSV (Sparkassen), MLP, PKV (private health insurance association), and Siemens. The firm's 25+ year operating history, DIN-certified financial analysis products, patented knowledge management technology, and systematic partnership-led expansion across Europe and into emerging markets collectively define its competitive posture in a niche but institutionally entrenched segment of the German and European healthcare data market.
REBMANN RESEARCH firmographics
Firmographics- Name
- REBMANN RESEARCH
- Legal name
- REBMANN RESEARCH GmbH & Co. KG
- Website
- https://rebmann-research.de
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- REBMANN RESEARCH provides proprietary economic data and cloud-based analytics tools covering 60 healthcare sectors, serving financial consultants, medical practice owners, banks, and insurers in Europe and Latin America through products like Atlas Medicus, Medicus ONE, CURE Praxismanager, and Finoso.
- Ownership category
- akta.pro rank
REBMANN RESEARCH industry classification
Industry- Product category
- Healthcare Market Intelligence Software
- NAICS
- Marketing Research and Public Opinion Polling (54191), Other Scientific and Technical Consulting Services (54169), Marketing Research and Public Opinion Polling (541910)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)
- akta.pro primary industry
- Industry & Sector Research (Syndicated/Custom) (BPAHALAE)
- akta.pro secondary industry
- Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN)
Keywords
Where REBMANN RESEARCH is headquartered
LocationHeadquarters
- HQ city
- Schramberg
- HQ country
- Germany
- HQ region
- Europe
Offices3 records
Markets served
REBMANN RESEARCH business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Software Subscriptions (Atlas Medicus, Guided Medicus, Medicus ONE, Finoso): Cloud-based software tools provided as subscriptions through the Atlas Medicus platform. Atlas Medicus includes economic data updated at least annually, interactive analysis tools, and business planning applications. Free trial available for Atlas Medicus.
- Publication Licensing: Market research publications (Atlas Dental, etc.) sold as online and print licenses. Short versions available free; full long versions available for purchase (e.g., Atlas Dental Europe 2024 at 900 EUR license fee, Atlas Dental Latin America & Caribbean 2025/2026 at 960 EUR). Annual access for purchased publications with optional renewal.
- Consulting Services / White-label Licensing: CURE Praxismanager and Rebmann Research tools offered as white-label to banks and specialist advisors (Embedded Partner model), enabling them to provide real-time advisory services to healthcare practice clients.
- Sponsored Studies and Research: Commissioned market studies produced for organizations such as GFDI (Gesellschaft zur Förderung der Dental-Industrie mbH) for official publications like the Atlas Dental series.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Atlas Dental Europe 2024 (Long Version) - 250-page comprehensive study |
| Subscription | Annual | Atlas Dental Latin America & Caribbean 2025/2026 (Long Version) |
| Freemium | Annual | Atlas Dental Short Versions (free tier) |
| Freemium | Pay-as-you-go | Atlas Medicus Free Trial |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels7 records
REBMANN RESEARCH product offering
Product offeringCore offering
REBMANN RESEARCH provides cloud-based economic data and analytics software for the healthcare market, covering approximately 60 healthcare sectors in Germany and Europe. Its product family centers on four core software tools: Atlas Medicus (market information and consulting toolbox), Guided Medicus (strategic practice planning), Medicus ONE (real-time practice controlling via Open Banking with Machine Learning), and Finoso (DIN 77230/77235 compliant financial advisory software). The company also publishes major market research studies (Atlas Dental series) and operates the Forum Medicum event platform. Target customers include specialized healthcare consultants, medical/dental practice owners, banks, insurance firms, and public sector institutions.
Product overview
REBMANN RESEARCH offers a comprehensive digital platform for economic data and financial analysis in the healthcare market, covering approximately 60 healthcare sectors. The product portfolio centers on four main software products: Atlas Medicus (market information and analysis toolbox for consultants), Guided Medicus (strategic consulting tool for practice planning), Medicus ONE (real-time practice controlling via bank account connection), and Finoso (DIN-compliant financial advisory software). The company also offers the patented Atlas Explorer and Hit-O-Meter knowledge management technologies, publishes major market research studies (Atlas Dental series), and operates the Forum Medicum event platform. Following the 2024 majority acquisition of CURE Vertical Finance GmbH, the portfolio expanded to include the CURE Praxismanager (Open Banking practice management). All products are designed for healthcare professionals, specialized consultants, banks, insurance companies, and public institutions.
Differentiator
Problem solved
Functional benefit
Brands
- Atlas Medicus: The toolbox for top healthcare consultants - includes practice planner for revenue, investment and earnings planning, competitive analysis applications, inventory estimation, and practice valuation tools. Customers include specialized financial, tax and business consultants, KVEs, physician associations, physician networks, dental and medical technology sales, and other healthcare service providers.
- Guided Medicus
- Medicus ONE
- Finoso
- CURE Praxismanager
- Gesundheitsmarktwissen
- Forum Medicum
Products and services
- Atlas Medicus Cloud-based market information system and consulting toolbox providing economic data and interactive analysis tools for approximately 60 healthcare sectors in Germany and Europe. Includes the Praxisplaner (practice planner) for revenue, investment, and earnings planning, plus applications for competitive analysis, inventory estimation, and on-demand practice valuation. Primary users are specialized financial, tax, and business consultants for healthcare practices, KVen, physician associations, physician networks, and medical technology distributors.
- Medicus ONE Real-time practice controlling tool that connects directly to practice bank accounts. Analyzes practice revenue, expenses, liquidity, and tax projections using Machine Learning and AI interpretation, requiring only a bank account connection with no additional data entry. Used by practice owners and their financial advisors for live practice economics monitoring.
- Guided Medicus Cloud-based strategic consulting tool for practice founding, growth, and succession planning. Places professional and personal life goals of consulting clients at the center and highlights success potentials of the practice business via integrated market data. Supports honorarberatung (fee-based consulting) and business plan creation. Used by consultants seeking a holistic strategic consulting approach.
- Finoso (Privat & Gewerbe) DIN-compliant financial advisory software certified by DEFINO Institut für Finanznorm AG. Comprises Finoso Privat (certified per DIN 77230 for private clients) and Finoso Gewerbe (certified per DIN 77235 for commercial clients), enabling standardized financial advice on retirement and insurance products. Targets practice owners and financial/tax/business consultants.
- CURE Praxismanager Cloud-based Open Banking platform specifically developed for healthcare professionals (Heilberufe). Connects bank accounts, automatically captures, structures, and categorizes payment flows, and uses Machine Learning algorithms for predictive financial forecasting and real-time economic analysis of medical practices. First multi-bank Open Banking platform designed for medical/dental practice needs. Integrated with medondo AG practice management software.
- Atlas Dental Publications Market research publications covering dental industry structures, challenges, and trends across European and international markets. Includes Atlas Dental Europe (11 countries, 250 pages, 900 EUR license fee), Atlas Dental Special Edition IDS 2025 (10 markets), Atlas Dental Latin America & Caribbean (17 countries, 194 chapters, 960 EUR), and sector-specific healthcare studies. Short versions are freely accessible; long versions licensed annually with renewal option.
Quantifiable outcome
- Market data across 60 healthcare sectors updated comprehensively at least once per year
- +2 more outcomes
Companies that use REBMANN RESEARCH
Customer profileNamed customers13 records
Segments5 records
Ideal customer profiles5 records
REBMANN RESEARCH technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability3 records
Feature7 records
REBMANN RESEARCH partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered minor and core.
- Hauck Aufhäuser Lampe (HAL)minorRebmann Research contributed expert analysis to HAL's Market Report on Ambulatory Healthcare Properties. Dr. Bernd Rebmann analyzed the regional distribution of outpatient healthcare properties using Atlas Medicus data. Andrea Kern-Schnur contributed cost structure analysis. The report identified approximately €30 billion market volume for outpatient healthcare properties.
- KOCK CONSULTINGcoreJoint development of a revolutionary On-Demand consulting concept that synchronizes performance analysis with real-time data from practices and benchmarks it against Rebmann Research database comparisons. KOCK CONSULTING (formerly Kock & Voeste) brings over 30 years of experience and 12,500+ completed consulting mandates. The solution replaces traditional Excel-based methods with a database-driven quality assurance approach.
- FINO Software GmbHcoreDeepening an existing multi-year cooperation to offer an integrated solution for financial advisors in the healthcare professional market. The partnership integrates FINO's DIN-compliant analysis software (Finoso Privat certified to DIN 77230, Finoso Gewerbe to DIN 77235) into Rebmann Research's product portfolio, enabling standardized financial advice on retirement and insurance products for healthcare practice clients.
- medondo AGcoreRebmann Research integrated its AI-based CURE Praxismanager practice controlling into the medondo coordinator all-in-one cloud practice management system. The integration targets the same-day digitalization of practice workflows including patient communication, appointment scheduling, telemedicine, and financial management. The joint solution claims to save up to 2 employees per practice through process automation.
- GFDI (Gesellschaft zur Förderung der Dental-Industrie mbH) / VDDI (Verband der Deutschen Dental-Industrie)coreGFDI commissioned Rebmann Research to produce the Atlas Dental Europa 2024 study, building on a partnership that began in 2019. GFDI is the commercial enterprise of VDDI (German Dental Industry Association). Atlas Dental studies serve as official companion studies for the IDS (International Dental Show) in Cologne. The 2024 study was the first produced independently by Rebmann Research after the initial 2019 collaboration.
- CURE Vertical Finance GmbHcoreRebmann Research acquired a majority stake in the Berlin-based FinTech CURE Vertical Finance GmbH in February 2024. CURE developed the first Multi-Bank/Open Banking platform specifically for medical and dental practices. The integration brought CURE Praxismanager into the Rebmann Research product family, enabling real-time practice financial analysis powered by Machine Learning. The combined entity aims to build a European powerhouse for AI-supported analysis of economic health and financial data.
- University of Health Sciences (UMIT), Hall, AustriaminorPartnership established in 2011-2015 period for the launch of Atlas Medicus Austria, extending the market information system into the Austrian healthcare market.
Scale indicators9 records
Recent moves6 records
Expansion highlights5 records
REBMANN RESEARCH competitors and assessment
Company assessmentBroad incumbents
- DATEV eG: German cooperative providing tax, accounting, and consulting software to tax advisors and accountants — the same Heilberufeberater channel that Rebmann Research addresses. DATEV's broad financial-advisor platform overlaps with Rebmann's Atlas Medicus consulting tool position.
- CompuGroup Medical (CGM): One of Europe's largest e-health and practice management software providers, serving physicians, dentists, hospitals and pharmacies with practice administration, billing, and clinical software. Competes broadly with Rebmann's practice-side tools via a much larger product portfolio and installed base.
- IQVIA Germany: Global healthcare data, analytics, and market research firm with a German practice covering pharmaceutical, medical technology, and provider market intelligence. Competes in the broader healthcare market research category where Rebmann Research's Atlas Dental and Atlas Medicus publications sit, though at vastly larger scale and scope.
Direct peers
- Zentralinstitut für die kassenärztliche Versorgung (Zi): German research institute that analyzes nationwide claims and supply data for the statutory outpatient physician sector, producing benchmarking and economic analyses for physician services. Closely comparable as a publisher of authoritative German healthcare economic data used by the same advisor and association audiences Rebmann Research serves.
- medatixx GmbH & Co. KG: German provider of practice management and billing software for medical and dental practices, serving a similar Heilberufe end-customer base. Competes in the practice software category that CURE Praxismanager and Medicus ONE target.
- Stiftung Gesundheit: German nonprofit that publishes structured market data on healthcare providers and produces the 'Arzt-Auskunft' professional directory for the German healthcare market. Comparable as a publisher of healthcare market intelligence serving overlapping practitioner and advisor audiences.
- KOCK CONSULTING: Specialized German consulting firm for medical and dental practices with 12,500+ completed mandates and 30+ years of history. Joint go-to-market partner with Rebmann Research for the on-demand consulting concept that integrates KOCK's advisory methodology with Rebmann's Atlas Medicus benchmarking data.
- medondo AG: German practice management software provider offering the medondo coordinator all-in-one cloud platform for dental, human medicine, and veterinary practices. Direct technology integration partner with Rebmann Research — CURE Praxismanager is embedded into medondo's platform — and operates in the same Heilberufe practice-software category.
- FINO Software GmbH: Provider of the Finoso DIN-compliant financial analysis software (Finoso Privat certified to DIN 77230 and Finoso Gewerbe to DIN 77235). Finoso is now integrated into Rebmann Research's portfolio under a deepening technology partnership, making FINO both a partner and a directly comparable product in the same DIN-compliant advisor software category.
Others
- Deutsche Apotheker- und Ärztebank (apoBank): German bank specialized in serving Heilberufe professionals (physicians, dentists, pharmacists). Serves the same end-customer audience that Rebmann Research addresses through its advisor and white-label bank channel products, and is a potential white-label partner rather than direct competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
REBMANN RESEARCH social profiles
Digital presenceREBMANN RESEARCH financial estimates
Financial estimateRevenue estimate
Valuation estimate
REBMANN RESEARCH leadership team
Management profileNumber of profiles
Profiles9 records
REBMANN RESEARCH subsidiaries and ownership
Company hierarchySubsidiaries1 record
REBMANN RESEARCH funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
REBMANN RESEARCH M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about REBMANN RESEARCH
What does REBMANN RESEARCH do?
REBMANN RESEARCH provides cloud-based economic data and analytics software for the healthcare market, covering approximately 60 healthcare sectors in Germany and Europe. Its product family centers on four core software tools: Atlas Medicus (market information and consulting toolbox), Guided Medicus (strategic practice planning), Medicus ONE (real-time practice controlling via Open Banking with Machine Learning), and Finoso (DIN 77230/77235 compliant financial advisory software). The company also publishes major market research studies (Atlas Dental series) and operates the Forum Medicum event platform. Target customers include specialized healthcare consultants, medical/dental practice owners, banks, insurance firms, and public sector institutions.
Is REBMANN RESEARCH a public or private company?
REBMANN RESEARCH is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was REBMANN RESEARCH founded?
REBMANN RESEARCH was founded in 1998. It employs 11 to 50 people.
Where is REBMANN RESEARCH based?
REBMANN RESEARCH is headquartered in Schramberg, Germany, in the Europe region.
How does REBMANN RESEARCH make money?
Four revenue lines are on record. Software Subscriptions (Atlas Medicus, Guided Medicus, Medicus ONE, Finoso) is the primary driver. The others are publication Licensing, consulting Services / White-label Licensing and sponsored Studies and Research.
Who are REBMANN RESEARCH's main competitors?
Broad incumbents on record are DATEV eG, CompuGroup Medical (CGM) and IQVIA Germany. Direct peers are Zentralinstitut für die kassenärztliche Versorgung (Zi), medatixx GmbH & Co. KG, Stiftung Gesundheit, KOCK CONSULTING, medondo AG and FINO Software GmbH. Deutsche Apotheker- und Ärztebank (apoBank) is listed as an others.
Does REBMANN RESEARCH have an API?
No public API is recorded for REBMANN RESEARCH.
What industry is REBMANN RESEARCH in?
REBMANN RESEARCH's product category is Healthcare Market Intelligence Software. Its primary akta.pro industry code is BPAHALAE, Industry & Sector Research (Syndicated/Custom), with a secondary code of BPAHALAN, Healthcare Outcomes & Real-World Evidence (RWE) Analytics. Its NAICS code is 54191 and its SIC code is 8731.